{"content":"<li class=\"n-box-item date-title\" data-end=\"1448254799\" data-start=\"1448168400\" data-txt=\"Sunday, December 22, 2019\">Sunday, November 22, 2015</li><li class=\"n-box-item sa-box-item\" data-id=\"2945616\" data-ts=\"1448241800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2945616-wsj-pfizer-and-allergan-agree-to-150b-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Pfizer and Allergan agree to $150B merger</a></h4><ul>\n<li>In what would be the largest \"inversion\" deal ever, the boards of Pfizer (NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>) and Allergan (NYSE:<a href=\"https://seekingalpha.com/symbol/AGN\" title=\"Allergan plc\">AGN</a>) have agreed to merge, <a href=\"http://www.wsj.com/articles/pfizer-allergan-on-cusp-of-merger-deal-1448217490\" target=\"_blank\">reports the <em>WSJ</em></a>, with an official announcement perhaps coming tomorrow.</li>\n<li>The deal, of course, comes days after Treasury issued new rules aimed at curbing such deals, but analysts say the new measures don't put this particular merger at risk. Global antitrust regulators will be sure and have their say, though.</li>\n<li>Pfizer CEO Ian Read - an outspoken critic of high U.S. corporate tax rates - will lead the combined company, says the <em>Journal</em>, with Allergan CEO Brent Saunders serving as president and COO.</li>\n<li>The final terms would have Allergan shareholders receiving 11.3 Pfizer shares for each share of AGN they own, say sources, and there's also a small cash component. Pfizer closed Friday at $32.18, making just the stock portion worth $363.63 vs. Allergan's close of $312.84.</li>\n<li>The companies are planning for seven to nine months before closing. The combined entity is then expected to evaluate splitting into two businesses - one focused on patent-protected products and the other on drugs that have already lost it (or are close to).</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2939736-pfizer-said-to-be-near-deal-to-buy-allergan-for-as-much-as-380-share\" target=\"_blank\">Pfizer said to be near deal to buy Allergan for as much as $380/share</a> (Nov. 18)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2943306-will-the-new-inversion-rules-derail-a-pfizer-allergan-deal\" target=\"_blank\">Will the new inversion rules derail a Pfizer-Allergan deal?</a> (Nov. 20)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2945616\" data-linked=\"WSJ: Pfizer and Allergan agree to $150B merger\" data-tweet=\"$PFE $PFE $AGN - WSJ: Pfizer and Allergan agree to $150B merger https://seekingalpha.com/news/2945616-wsj-pfizer-and-allergan-agree-to-150b-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/2945616-wsj-pfizer-and-allergan-agree-to-150b-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>90&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":1,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}